SCHEMBL1476073

SCHEMBL1476073

Nc1cccc(-c2cc(C(=O)NCCc3ccncc3)no2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.63
FAAH O00519 5/20 0.63
HDAC3 O15379 2/20 0.62
HDAC1 Q13547 2/20 0.62
HDAC2 Q92769 2/20 0.62
HDAC10 Q969S8 2/20 0.62
HDAC8 Q9BY41 2/20 0.62
HDAC6 Q9UBN7 2/20 0.62
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.54
HSD17B10 Q99714 1/20 0.54
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
POLB P06746 1/20 0.52
HIF1A Q16665 2/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1475553 0.88 RAB9A (0.62) MAPTFAAHHDAC3HDAC1HDAC2
SCHEMBL1474945 0.88 MAPT (0.64) MAPTFAAHALDH1A1HPGDLMNA
SCHEMBL1474540 0.87 FAAH (0.67) MAPTFAAHHDAC3HDAC1HDAC2
SCHEMBL1474935 0.87 FAAH (0.81) MAPTFAAHHDAC3HDAC1HDAC2
SCHEMBL1474724 0.87 MAPT (0.63) MAPTFAAHHDAC6ALDH1A1HPGD
SCHEMBL1474570 0.84 FAAH (0.62) MAPTFAAHALDH1A1HPGDLMNA
SCHEMBL1474441 0.84 MAPT (0.75) MAPTFAAHALDH1A1HPGDLMNA
SCHEMBL15190281 0.83 HDAC3 (0.44) MAPTFAAHHDAC3HDAC1HDAC2
SCHEMBL1476525 0.83 MAPT (0.59) MAPTFAAHALDH1A1HPGDLMNA
SCHEMBL1476942 0.81 FAAH (0.80) MAPTFAAHHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 MAPT 2497/4885FAAH 4712/4885HDAC3 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.